Argenx Se (ARGX) Interest Expenses (2019 - 2025)
Argenx Se's (ARGX) quarterly Interest Expenses came in at $448000.0 in Q2 2022, down 87.41% YoY from $3.6 million in Q2 2021, and up 147.01% on a QoQ basis from -$953000.0 in Q1 2022.
Argenx Se (ARGX) Interest Expenses (2019 - 2025) Analysis & Trends
Argenx Se (ARGX) has 3 years of Interest Expenses data on file, last reported at $448000.0 in Q2 2022.
- Quarterly Interest Expenses fell 87.41% year-over-year to $448000.0 in Q2 2022, while the trailing twelve-month figure through Mar 2023 was $448000.0 (down 82.8% YoY) and the FY2025 annual result came in at $4.1 million, up 65.67% from the prior year.
- Interest Expenses improved to $448000.0 in Q2 2022, from -$953000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $3.6 million in Q2 2021 to a low of -$1.2 million in Q1 2021.
- A 3-year average of $342842.6 and a median of $94527.9 in 2019 frame the typical range for Interest Expenses.
- The widest YoY moves for Interest Expenses: up 19.51% in 2022, down 87.41% in 2022.
- Tracing ARGX's Interest Expenses over 3 years: stood at $231339.5 in 2019, then surged by 1437.57% to $3.6 million in 2021, then plunged by 87.41% to $448000.0 in 2022.
- The last three Interest Expenses figures came in at $448000.0 (Q2 2022), -$953000.0 (Q1 2022), and $3.6 million (Q2 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | 6.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -900,000.00 |
| Dec 31, 2025 | -900,000.00 |
| Jun 30, 2025 | -664.00 Mn |
| Jun 30, 2025 | -664.00 Mn |
| Dec 31, 2024 | -392,000.00 |
| Dec 31, 2024 | -392,000.00 |
| Jun 30, 2024 | -157.00 Mn |
| Jun 30, 2024 | -157.00 Mn |
| Dec 31, 2023 | -211,000.00 |
| Dec 31, 2023 | -211,000.00 |
| Jun 30, 2023 | -78,000.00 |
| Jun 30, 2023 | -78,000.00 |
| Dec 31, 2022 | -851,000.00 |
| Dec 31, 2022 | -851,000.00 |
| Jun 30, 2022 | 448,000.00 |
| Jun 30, 2022 | 448,000.00 |
| Mar 31, 2022 | -953,000.00 |
| Mar 31, 2022 | -953,000.00 |
| Jun 30, 2021 | 3.56 Mn |
| Jun 30, 2021 | 3.56 Mn |